-
Published25/11/2024
-
Today02/12/2024
-
Deadline09/12/2024
-
Opening of tenders09/12/2024
Utilities
- indicates text translated automatically in your browsing language
Drug supply - Active substance teduglutide - ATC A16AX08 Text automatically translated in your browsing language Automatically translated
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
The subject of the contract is the continuous supply of a medicinal product containing the active substance teduglutide – ATC A16AX08. LL - teduglutide, dosage form 5MG INJ PSO LQF 28+28X0,5ML ISP, unit of measurement 28+28X0,5ML, amount of 90 LL - teduglutide, dosage form 1,25MG INJ PSO LQF 28+28X0,5ML ISP, unit of measurement 28+28X0,5ML, amount of 10 Text automatically translated in your browsing language Automatically translated
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.